Ultrasound-Mediated Gemcitabine Delivery Reduces the Normal-Tissue Toxicity of Chemoradiation Therapy in a Muscle-Invasive Bladder Cancer Model. (2021)
Attributed to:
OxCD3: Oxford Centre for Drug Delivery Devices
funded by
EPSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.ijrobp.2020.11.046
PubMed Identifier: 33714528
Publication URI: http://europepmc.org/abstract/MED/33714528
Type: Journal Article/Review
Volume: 109
Parent Publication: International journal of radiation oncology, biology, physics
Issue: 5
ISSN: 0360-3016